Windlas Biotech bulk deals, insider trading and stake changes
NSE: WINDLASBSE: 543329Pharmaceuticals & BiotechnologySmall Cap
Last close ₹872.70down ₹27.70 (3.08%)BSE ₹872.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹900.40.
52-week range of traded prices to 23 Oct 2026
₹697.40Low, 16 Mar 2026₹1,181.90High, 7 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,801 Cr1,237th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 27.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 Jul 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.72%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 12.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 Jul 2026
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 92,52449.2% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Windlas Biotech promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Others: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Windlas Biotech insider trading
All 34 disclosures on record.Insider trading, all companies
Sep 2026
- SUDAM KUMAR PRADHAN₹0.24 Cr2,200 sharesSold or invoked · Designated Person · 29 Sep 2026 · disclosed 7 Oct
- VIJAY BHIMRAO KARE₹0.11 Cr1,000 sharesSold or invoked · Designated Person · 2 Sep 2026 · disclosed 30 Sep
- ROSHAN MON₹0.20 Cr2,000 sharesSold or invoked · Designated Person · 1 Sep 2026 · disclosed 30 Sep
Jun 2026
- ROSHAN MON₹0.40 Cr4,907 sharesSold or invoked · Designated Person · 19 Jun 2026 · disclosed 24 Jun
Mar 2026
- ROSHAN MON₹0.61 Cr8,000 sharesBought · Designated Person · 24 Mar 2026 · disclosed 7 Apr
Feb 2026
- MOHD. ASLAM₹0.22 Cr2,769 sharesSold or invoked · Designated Person · 17 Feb 2026 · disclosed 7 Apr
- MOHD. ASLAM₹0.11 Cr1,431 sharesSold or invoked · Designated Person · 16 Feb 2026 · disclosed 7 Apr
Sep 2025
- MUNISH KAPOOR₹0.04 Cr400 sharesSold or invoked · Designated Person · 25 Sep 2025 · disclosed 29 Sep
- ROSHAN MON₹0.49 Cr5,000 sharesSold or invoked · Designated Person · 18 Sep 2025 · disclosed 25 Sep
- ROSHAN MON₹0.19 Cr1,952 sharesSold or invoked · Designated Person · 17 Sep 2025 · disclosed 24 Sep
- OM PRAKASH SULE₹0.59 Cr6,000 sharesSold or invoked · Designated Person · 17 Sep 2025 · disclosed 24 Sep
- MOHD. ASLAM₹1.10 Cr11,085 sharesSold or invoked · Designated Person · 15 Sep 2025 · disclosed 23 Sep
- KOMAL GUPTA₹1.98 Cr20,000 sharesBought · Designated Person · 10 Sep 2025 · disclosed 15 Sep
- HARGOVIND SETH₹0.14 Cr1,415 sharesBought · Designated Person · 10 Sep 2025 · disclosed 15 Sep
- MUNISH KAPOOR₹0.05 Cr500 sharesSold or invoked · Designated Person · 10 Sep 2025 · disclosed 15 Sep
- MOHD. ASLAM₹1.51 Cr15,262 sharesBought · Designated Person · 10 Sep 2025 · disclosed 15 Sep
- MUNISH KAPOOR₹0.12 Cr1,200 sharesBought · Designated Person · 10 Sep 2025 · disclosed 15 Sep
- ROSHAN MON₹0.69 Cr6,952 sharesBought · Designated Person · 10 Sep 2025 · disclosed 15 Sep
- MOHD. ASLAM₹32,25030 sharesSold or invoked · Designated Person · 10 Sep 2025 · disclosed 15 Sep
- OM PRAKASH SULE₹0.60 Cr6,000 sharesBought · Designated Person · 10 Sep 2025 · disclosed 15 Sep
- SUDAM KUMAR PRADHAN₹0.11 Cr1,060 sharesBought · Designated Person · 10 Sep 2025 · disclosed 15 Sep
Aug 2025
- PAWAN KUMAR SHARMA₹0.10 Cr950 sharesSold or invoked · Designated Person · 18 Aug 2025 · disclosed 21 Aug
- MOHD. ASLAM₹0.16 Cr1,500 sharesSold or invoked · Designated Person · 18 Aug 2025 · disclosed 21 Aug
- JOGENDRA SINGH₹0.34 Cr3,200 sharesSold or invoked · Designated Person · 18 Aug 2025 · disclosed 21 Aug
- PAWAN KUMAR SHARMA₹1.07 Cr10,175 sharesPledge · Designated Person · 14 Aug 2025 · disclosed 20 Aug
Earlier, Jun 2024 to Mar 2025Hide earlier
Mar 2025
- MOHD. ASLAM₹0.16 Cr1,500 sharesSold or invoked · Designated Person · 27 Mar 2025 · disclosed 2 Apr
- ROSHAN MON₹0.20 Cr2,005 sharesSold or invoked · Designated Person · 25 Mar 2025 · disclosed 30 Mar
Feb 2025
- ROSHAN MON₹0.49 Cr6,000 sharesSold or invoked · Designated Person · 20 Feb 2025 · disclosed 3 Mar
Jun 2024
- OM PRAKASH SULE₹0.07 Cr999 sharesSold or invoked · Designated Person · 24 Jun 2024 · disclosed 28 Jun
- OM PRAKASH SULE₹0.76 Cr10,561 sharesBought · Designated Person · 21 Jun 2024 · disclosed 25 Jun
- KOMAL GUPTA₹0.89 Cr12,354 sharesBought · Designated Person · 21 Jun 2024 · disclosed 25 Jun
- HARGOVIND SETH₹0.15 Cr2,122 sharesBought · Designated Person · 21 Jun 2024 · disclosed 25 Jun
- MUNISH KAPOOR₹0.21 Cr2,870 sharesBought · Designated Person · 21 Jun 2024 · disclosed 25 Jun
- JOGENDRA SINGH₹0.15 Cr2,100 sharesBought · Designated Person · 21 Jun 2024 · disclosed 25 Jun
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Windlas Biotech stake sales and purchases
All 6 disclosures on record.
May 2026
- SoldICICI Prudential Mutual Fund2.63% of the company5,40,642 sharesholds 4.33% after13 May 2026 · filed under the 2% rule · Open Market
Jul 2024
- SoldICICI Prudential Mutual Fund2.32% of the company5,04,359 sharesholds 6.96% after29 Jul 2024 · filed under the 2% rule
Mar 2023
- AcquiredICICI Prudential Mutual Fund2.01% of the company3,75,091 sharesholds 9.27% after19 Mar 2023 · filed under the 2% rule
- AcquiredAshok Kumar Windlass alongwith PAC · promoterholds 59.95% after9 Mar 2023 · filed under the 2% rule
Apr 2022
- AcquiredICICI Prudential Mutual Fund2.11% of the company4,61,218 sharesholds 7.26% after19 Apr 2022 · filed under the 2% rule · Open market
Nov 2021
- AcquiredICICI Prudential Mutual Fund0.23% of the company50,000 sharesholds 5.15% after2 Nov 2021 · filed under the 5% rule
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Windlas Biotech bulk deals
Last 12 months, since 23 Oct 2025: 2 bulk deals, ₹11 Cr bought and ₹11 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Tuesday 11 Aug 20261 firm · ₹11 Cr bought · ₹11 Cr soldNet sold ₹52,198
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 1,18,632 at ₹935.99Sold 1,18,632 at ₹936.430.57% of the companyNet nil₹11 Cr bought
Thursday 20 Feb 20251 firm · ₹11 Cr bought · ₹0 soldNet bought ₹11 Cr
- BoughtAJAY KUMAR AGGARWALBought 1,44,995 at ₹787.420.69% of the company₹11 Cr
Wednesday 19 Feb 20251 firm · ₹0 bought · ₹7.89 Cr soldNet sold ₹7.89 Cr
- SoldSAMVITTI CAPITAL PRIVATE LIMITED ACTIVE ALPHA MULTICAPSold 1,15,374 at ₹683.490.55% of the company₹7.89 Cr
Friday 1 Mar 20241 firm · ₹6.26 Cr bought · ₹6.25 Cr soldNet bought ₹0.01 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 1,10,668 at ₹565.96Sold 1,10,668 at ₹564.940.53% of the companyNet nil₹6.26 Cr bought
Thursday 8 Feb 20241 firm · ₹7.07 Cr bought · ₹7.07 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 1,35,363 at ₹522.39Sold 1,35,363 at ₹522.270.65% of the companyNet nil₹7.07 Cr bought
Tuesday 2 Jan 20242 firms · ₹29 Cr bought · ₹26 Cr soldNet bought ₹2.66 Cr
- Both waysJAINAM BROKING LIMITEDBought 1,50,028 at ₹511.50Sold 96,128 at ₹520.700.72% of the companyNet +53,900 shares₹7.67 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 4,09,737 at ₹517.17Sold 4,09,737 at ₹517.501.97% of the companyNet nil₹21 Cr bought
Monday 1 Jan 20241 firm · ₹8.82 Cr bought · ₹8.83 Cr soldNet sold ₹0.01 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 1,85,662 at ₹475.10Sold 1,85,662 at ₹475.650.89% of the companyNet nil₹8.82 Cr bought
Monday 20 Nov 20231 firm · ₹5.51 Cr bought · ₹5.52 Cr soldNet sold ₹87,602
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 1,23,383 at ₹446.39Sold 1,23,383 at ₹447.100.59% of the companyNet nil₹5.51 Cr bought
Thursday 10 Aug 20231 firm · ₹4.74 Cr bought · ₹4.75 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 1,25,706 at ₹377.40Sold 1,25,706 at ₹377.570.60% of the companyNet nil₹4.74 Cr bought
Friday 7 Jul 20231 firm · ₹4.27 Cr bought · ₹4.28 Cr soldNet sold ₹71,588
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 1,27,836 at ₹333.97Sold 1,27,836 at ₹334.530.61% of the companyNet nil₹4.27 Cr bought
Monday 20 Sep 20211 firm · ₹0 bought · ₹4.31 Cr soldNet sold ₹4.31 Cr
- SoldKUBER INDIA FUNDSold 1,13,468 at ₹379.73₹4.31 Cr
Monday 16 Aug 20212 firms · ₹4.93 Cr bought · ₹10 Cr soldNet sold ₹5.11 Cr
- SoldICICI LTD TRADING A/CSold 1,22,350 at ₹417.62₹5.11 Cr
- Both waysALPHAGREP SECURITIES PRIVATE LIMITEDBought 1,16,009 at ₹425.28Sold 1,16,009 at ₹425.42Net nil₹4.93 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 24 deals on record since listing on 16 Aug 2021.